A new systematic review of animal studies testing a vaccine for tuberculosis raises questions about whether the studies provided sufficient evidence to move into trials of children. The new vaccine was a virus...
The century-old Bacille Calmette-Guérin (BCG) vaccine against tuberculosis is one of the world’s oldest and most widely used vaccines, used to immunize 100 million newborns every year. Given in countries with endemic...
In a study published in the journal ‘Cell Reports’, the research shows that the broad-spectrum effects of the Bacillus Calmette-Guerin (BCG) vaccine could be mediated by metabolic and epigenetic changes in white blood...
BCG, the only currently approved TB vaccine, has been around for almost a century and is only partially effective. When given to children, BCG is estimated to prevent 20% of infections and to protect half of the...
A recent study led by researchers from the University of California, Los Angeles revealed that a variant of a century-old vaccine is more effective at protecting against tuberculosis in animal models. The results of the...
Results from a highly anticipated clinical trial of the most advanced tuberculosis vaccine in 90 years showed that it failed to protect babies against the infectious disease, researchers said on Monday. The experimental...